inadvertent intrathecal injection of labetalol

Clicks: 129
ID: 128489
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Labetalol is a combined α and β adrenergic receptor blocker. It is used to treat hypertension, especially in pregnant patients. We report a case of a female patient who was given labetalol intrathecally in place of bupivacaine due to a similar appearance of ampoules which resulted in a drop in blood pressure and pulse rate. The patient responded to fluid resuscitation and there occurred no neurological sequelae.
Reference Key
verma2016saudiinadvertent Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;S Verma;P K Bhatia;V Sharma;P Sethi
Journal bulletin des sociétés chimiques belges
Year 2016
DOI
10.4103/1658-354X.174899
URL
http://www.saudija.org/article.asp?issn=1658-354X;year=2016;volume=10;issue=3;spage=345;epage=346;aulast=Verma
Keywords
labetalolanesthesiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.